Texas 2025 - 89th Regular

Texas Senate Bill SB984

Filed
1/29/25  
Out of Senate Committee
3/31/25  
Voted on by Senate
4/10/25  
Out of House Committee
5/5/25  
Voted on by House
5/20/25  
Governor Action
5/29/25  

Caption

Relating to access to individualized investigational treatments for patients with life-threatening or severely debilitating illnesses.

Companion Bills

TX HB975

Similar Relating to the right to try cutting-edge treatments for patients with life-threatening or severely debilitating illnesses.

TX HB3318

Same As Relating to access to individualized investigational treatments for patients with life-threatening or severely debilitating illnesses.

Previously Filed As

TX HB4059

Relating to the right to try cutting-edge treatments for patients with life-threatening or severely debilitating illnesses.

TX HB4348

Relating to the right to try cutting-edge treatments for patients with life-threatening or severely debilitating illnesses.

TX SB1580

Relating to the right to try cutting-edge treatments for patients with life-threatening or severely debilitating illnesses.

TX HB638

Relating to access to certain investigational drugs, biological products, and devices used in clinical trials by patients with severe chronic diseases.

TX SB773

Relating to access to certain investigational drugs, biological products, and devices used in clinical trials by patients with severe chronic diseases.

TX HB1200

Relating to authorizing the possession, use, cultivation, distribution, transportation, and delivery of medical cannabis for medical use by qualifying patients with certain debilitating medical conditions and the licensing of dispensing organizations and cannabis testing facilities; authorizing fees.

TX SB121

Relating to authorizing the possession, use, cultivation, distribution, delivery, sale, and research of medical cannabis for medical use by patients with certain medical conditions and the licensing of medical cannabis organizations; authorizing fees.

TX HB3162

Relating to advance directives, do-not-resuscitate orders, and health care treatment decisions made by or on behalf of certain patients, including a review of directives and decisions.

TX SB426

Relating to patient access to prescription drugs for off-label use for COVID-19 treatment.

TX SB1724

Relating to advance directives and health care treatment decisions made by or on behalf of patients, including a review of those directives and decisions.

Similar Bills

AZ SB1163

Individualized investigational treatment; availability; prohibitions

TX HB4348

Relating to the right to try cutting-edge treatments for patients with life-threatening or severely debilitating illnesses.

TX SB1580

Relating to the right to try cutting-edge treatments for patients with life-threatening or severely debilitating illnesses.

TX HB4059

Relating to the right to try cutting-edge treatments for patients with life-threatening or severely debilitating illnesses.

TX HB975

Relating to the right to try cutting-edge treatments for patients with life-threatening or severely debilitating illnesses.

TX HB3318

Relating to access to individualized investigational treatments for patients with life-threatening or severely debilitating illnesses.

TN SB0282

AN ACT to amend Tennessee Code Annotated, Title 53 and Title 63, relative to medical treatment.

TN HB0192

AN ACT to amend Tennessee Code Annotated, Title 53 and Title 63, relative to medical treatment.